A Global, Phase 1/2, Open Label, Dose Escalation Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3704 in Patients with Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Moderna Therapeutics, Inc.
Start Date
September 26, 2019
End Date
May 6, 2021
Administered By
Pediatrics, Medical Genetics
Awarded By
Moderna Therapeutics, Inc.
Start Date
September 26, 2019
End Date
May 6, 2021